Harvard Bioscience (HBIO) Return on Invested Capital (2011 - 2026)

Harvard Bioscience (HBIO) has 16 years of Return on Invested Capital data on file, last reported at 0.03% in Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.03%, up 4.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.03% (up 4.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital improved to 0.03% in Q1 2026 per HBIO's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.03% in Q1 2026 and troughed at 0.01% in Q2 2025.
• A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Invested Capital.
• The sharpest annual moves came in 2025 and 2026: Return on Invested Capital decreased 1 bps in 2025, then grew 4 bps in 2026.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then soared by 66 bps to 0.0% in 2023, then slumped by 324 bps to 0.0% in 2024, then sank by 1414 bps to 0.0% in 2025, then soared by 931 bps to 0.03% in 2026.
• Business Quant data shows HBIO's Return on Invested Capital at 0.03% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.